Pang et al., 1997 - Google Patents
Ocular actions of endothelinsPang et al., 1997
- Document ID
- 15706469621978797670
- Author
- Pang I
- Yorio T
- Publication year
- Publication venue
- Proceedings of the Society for Experimental Biology and Medicine
External Links
Snippet
Endothelins (ETs) represent a group of 21 amino acid-containing peptides that include two disulfide bridges. Endothelin was first isolated as the potent vasoconstrictor from supernatants of cultured endothelial cells (1) and appears to be evolutionary related to a …
- 102000002045 Endothelin 0 title abstract description 32
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pang et al. | Ocular actions of endothelins | |
| US6555321B1 (en) | Methods for determining cell responses through EphB receptors | |
| Wiechmann et al. | Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues | |
| Krauss et al. | Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models | |
| MacCumber et al. | Ocular effects of the endothelins: abundant peptides in the eye | |
| Rosenthal et al. | Expression of bestrophin‐1, the product of the VMD2 gene, modulates voltage‐dependent Ca2+ channels in retinal pigment epithelial cells | |
| US6268163B1 (en) | Identification of drug candidates modulating factor VII-mediated intracellular signaling | |
| Moens et al. | Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system | |
| US9856299B2 (en) | Use of immunesuppressant receptor | |
| KR20040025875A (en) | Method for the treatment of neurological and neuropsychological disorders | |
| MXPA03011331A (en) | Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels. | |
| Prasanna et al. | Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: pitfalls, promises and what lies ahead? | |
| CA2545777A1 (en) | Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents | |
| JP4086324B2 (en) | Neurturin receptor | |
| AU2003269626A1 (en) | Compositions and methods for treating heart disease | |
| Chakravarthy et al. | Endothelin: a new vasoactive ocular peptide. | |
| Dal Monte et al. | Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2 | |
| WO2016112012A1 (en) | Trkb agonists as novel treatment for acute and chronic cardiac disease | |
| Osaka | The EP3 and EP4 Receptor Subtypes both Mediate the Fever-producing Effects of Prostaglandin E2 in the Rostral Ventromedial Preoptic Area of the Hypothalamus in Rats | |
| Wu et al. | Effects of antiglaucoma drugs on calcium mobility in cultured corneal endothelial cells | |
| Lacheretz et al. | Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension | |
| Zhang et al. | Expression of adenylate cyclase subtypes II and IV in the human outflow pathway | |
| WO2011115106A1 (en) | Pharmaceutical for pseudo-exercise therapy | |
| Mokbel et al. | Rho-Kinase Inhibitors as a novel medication for Glaucoma Treatment–A Review of the literature | |
| i Luc | Ophthalmology Volume ll4, Number 6, June 2007 |